-
1
-
-
0037374498
-
The price of innovation: New estimates of drug development costs
-
DiMasi, J.A., Hansen, R.W., Grabowski, H.G., The price of innovation: new estimates of drug development costs, Journal of Health Economics (2003), 22, 151-185.
-
(2003)
Journal of Health Economics
, vol.22
, pp. 151-185
-
-
DiMasi, J.A.1
Hansen, R.W.2
Grabowski, H.G.3
-
2
-
-
0034002261
-
Role of the development scientist in compound lead selection and optimization
-
Venkatesh, S., Lipper, R.A., Role of the development scientist in compound lead selection and optimization, Journal of Pharmaceutical Science (2000) 89, 145- 154.
-
(2000)
Journal of Pharmaceutical Science
, vol.89
, pp. 145-154
-
-
Venkatesh, S.1
Lipper, R.A.2
-
3
-
-
0023947965
-
-
Prentis, R.A., Lis, Y., Walker, S.R., Pharmaceutical innovation by the seven U.K.-owned pharmaceutical companies (1964-1985), British Journal of Clinical Pharmacology (1988) 25, 387-396.
-
Prentis, R.A., Lis, Y., Walker, S.R., Pharmaceutical innovation by the seven U.K.-owned pharmaceutical companies (1964-1985), British Journal of Clinical Pharmacology (1988) 25, 387-396.
-
-
-
-
4
-
-
0030886937
-
-
Kennedy, T., Managing the drug discovery/development interface, DDT (1997), 2 (10), 436-444.
-
Kennedy, T., Managing the drug discovery/development interface, DDT (1997), 2 (10), 436-444.
-
-
-
-
6
-
-
84888003088
-
Physicochemical properties and the discovery of orally active drugs: Technical and people issues, Molecular Informatics: Confronting Complexity
-
Martin G. Hicks & Carsten Kettner Eds, May 13th-16th, Bozen, Italy
-
Lipinski, C.A., Physicochemical properties and the discovery of orally active drugs: technical and people issues, Molecular Informatics: Confronting Complexity, Martin G. Hicks & Carsten Kettner (Eds.) Proceedings or the Beilstein-Institut Worsho, May 13th-16th 2002, Bozen, Italy (2003).
-
(2002)
Proceedings or the Beilstein-Institut Worsho
-
-
Lipinski, C.A.1
-
7
-
-
19344374507
-
Improving Solubility in Lead Optimization
-
Faller, B., Improving Solubility in Lead Optimization, American Pharmaceutical Review, 7 (2004): 30-32.
-
(2004)
American Pharmaceutical Review
, vol.7
, pp. 30-32
-
-
Faller, B.1
-
8
-
-
0031024171
-
Experimental and computational apporaches to estimate solubility and permeability in drug discovery and development settings
-
Lipinski, C.A., Lombardo, F., Dominy, B.W., Feeney, P.J., Experimental and computational apporaches to estimate solubility and permeability in drug discovery and development settings, Advanced Drug Delivery Reviews (1997), 23, 3-25.
-
(1997)
Advanced Drug Delivery Reviews
, vol.23
, pp. 3-25
-
-
Lipinski, C.A.1
Lombardo, F.2
Dominy, B.W.3
Feeney, P.J.4
-
9
-
-
0343527392
-
Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards
-
Löbenberg, R., Amidon, G.L., Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards, European Journal of Pharmaceutics and Biopharmaceutics (2000) 50, 3-12.
-
(2000)
European Journal of Pharmaceutics and Biopharmaceutics
, vol.50
, pp. 3-12
-
-
Löbenberg, R.1
Amidon, G.L.2
-
10
-
-
1842689072
-
the 100 mg approach
-
Pharmaceutical evaluation of early development candidates
-
Balbach, S., Korn, C., Pharmaceutical evaluation of early development candidates "the 100 mg approach", International Journal of Pharmaceutics (2004) 275, 1-12.
-
(2004)
International Journal of Pharmaceutics
, vol.275
, pp. 1-12
-
-
Balbach, S.1
Korn, C.2
-
11
-
-
0031750861
-
-
Pharmaceutical Research
-
Galia, E., Nicolaides, E., Hörter, D. Lübenberg, R., Reppas, C., Dressman, J.B., Evaluation of various dissolution media for predicting in-vivo preformance of class I and II drugs, Pharmaceutical Research (1998) 15, 698-705.
-
(1998)
Evaluation of various dissolution media for predicting in-vivo preformance of class I and II drugs
, vol.15
, pp. 698-705
-
-
Galia, E.1
Nicolaides, E.2
Hörter, D.3
Lübenberg, R.4
Reppas, C.5
Dressman, J.B.6
-
12
-
-
17644367503
-
Poorly water-soluble drugs for oral delivery - a challenge for pharmaceutical development
-
Rasenack, N., Müller, B.W., Poorly water-soluble drugs for oral delivery - a challenge for pharmaceutical development, Pharm. Ind. (2005) 67, 323-326.
-
(2005)
Pharm. Ind
, vol.67
, pp. 323-326
-
-
Rasenack, N.1
Müller, B.W.2
-
13
-
-
21044453591
-
Poorly water-soluble drugs for oral delivery - a challenge for pharmaceutical development
-
Rasenack, N., Müller, B.W., Poorly water-soluble drugs for oral delivery - a challenge for pharmaceutical development, Pharm. Ind. (2005) 67, 447-451.
-
(2005)
Pharm. Ind
, vol.67
, pp. 447-451
-
-
Rasenack, N.1
Müller, B.W.2
-
14
-
-
20944434773
-
Poorly water-soluble drugs for oral delivery - a challenge for pharmaceutical development
-
Rasenack, N., Müller, B.W., Poorly water-soluble drugs for oral delivery - a challenge for pharmaceutical development, Pharm. Ind. (2005) 67, 583-591.
-
(2005)
Pharm. Ind
, vol.67
, pp. 583-591
-
-
Rasenack, N.1
Müller, B.W.2
-
15
-
-
4344593041
-
-
Chaubal, M.V., Application of formulation technologies in lead candidate selection and optimization, DDT (2004) 9 (14), 603-609.
-
Chaubal, M.V., Application of formulation technologies in lead candidate selection and optimization, DDT (2004) 9 (14), 603-609.
-
-
-
-
16
-
-
13444273611
-
Toward a Generic Apporach for Stress Testing of Drug Substances and Drug Products
-
Klick, S., Muijselaar, P.G., Waterval, J., Eichinger, T., Korn, C., Gerding, T.K., Debets, A.J., Sänger-van de Griend, C., van den Beld, C., Somsen, G.W., De Jong, G.J., Toward a Generic Apporach for Stress Testing of Drug Substances and Drug Products, Pharmaceutical Technology (2005), 2, 48-66.
-
(2005)
Pharmaceutical Technology
, vol.2
, pp. 48-66
-
-
Klick, S.1
Muijselaar, P.G.2
Waterval, J.3
Eichinger, T.4
Korn, C.5
Gerding, T.K.6
Debets, A.J.7
Sänger-van de Griend, C.8
van den Beld, C.9
Somsen, G.W.10
De Jong, G.J.11
-
17
-
-
0035897675
-
Crystalline Solids
-
Vippagunta, S.R., Brittain, H.G., Grant, D.J.W., Crystalline Solids, Advanced Drug Delivery Reviews (2001), 48, 3-26.
-
(2001)
Advanced Drug Delivery Reviews
, vol.48
, pp. 3-26
-
-
Vippagunta, S.R.1
Brittain, H.G.2
Grant, D.J.W.3
-
18
-
-
1042287180
-
Drug polymorphism and dosage form design: A practical perspective
-
Singhal, D., Curatolo, W., Drug polymorphism and dosage form design: a practical perspective, Advanced Drug Delivery Reviews (2004), 56, 335-347.
-
(2004)
Advanced Drug Delivery Reviews
, vol.56
, pp. 335-347
-
-
Singhal, D.1
Curatolo, W.2
-
19
-
-
0034874245
-
Ritonavir: An extraordinary example of conformational polymorphism
-
Bauer, J., Spanton, S., Henry, R., Quick, J., Dziki, W., Porter, W., Morris, J., Ritonavir: an extraordinary example of conformational polymorphism, Pharmaceutical Research (2001), 18, 859-866.
-
(2001)
Pharmaceutical Research
, vol.18
, pp. 859-866
-
-
Bauer, J.1
Spanton, S.2
Henry, R.3
Quick, J.4
Dziki, W.5
Porter, W.6
Morris, J.7
|